Gastro Oesophageal Reflux Disease
5
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease
Validation Of A Parent Administered Symptom Score For Unsettled Infants (Every Baby is UnIQue)
Clinical Investigation to Assess the Acid Neutralisation Activity of a Calcite Chewing Gum
Influence of Wrap Fixation Technique on the Results of Fundoplication
A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions